DISCLOSEDQuarterly
Oaktree Capital Management
Arrowhead Pharmaceuticals Inc · NASDAQ
9,146,000 sh · $11.0M
Filed 30 Jun 2026SEC 13Fview source
Oaktree Capital Management
Arrowhead Pharmaceuticals Inc · NASDAQ
9,146,000 sh · $11.0M
Oaktree Capital Management
Arrowhead Pharmaceuticals Inc · NASDAQ
11,055,000 sh · $11.5M